Baylor College of Medicine

Texas Children's Cancer Center and Hematology Service

Texas Children's Hospital

The Center
Patients and Families
Medical Education & Training
Health & Research Professionals
  • Overview for Patients and Families
  • For Referring Physicians
  • For Parents of New Patients
  • Programs & Centers
  • Meet Our Clinicians
  • Treatment Teams
  • Clinical Trials
  • Disease Information
  • Patient Resources
  • The Adolescent Program
  • Arts in Medicine Program
  • Contact Us
  • Search/Site Index
 
Arts In Medicine Program
"Untitled"
Jessica - 14

 
Clinical Trials
Clinical Trials Solid Tumor Clinical Trials Brain Tumor Clinical Trials Neuroblastoma-specific Clinical Trials Intrathecal Agent Clinical Trials Leukemia and Lymphoma Clinical Trials Center for Cell and Gene Therapy Clinical Trials Sickle Cell Clinical Trials
Related Pages
Programs & Centers Neuroblastoma Program Teams Solid Tumor Team Diseases Neuroblastoma

Neuroblastoma-specific Clinical Trials

For a Newly Diagnosed Patient

There are currently no listings. Please check back.

For a Patient with Recurrent or Relapsed Disease

NANT 2001-02: Phase I Study of CEP-701 (New Agent)

NANT 2003-01: Phase I Study of Oral Irinotecan, Temozolomide, and Cefixime (New Agent)

NANT 2004-01 Phase I Trial of Zometa with Cyclophosphamide (New Agent)

NANT 2004-04: Phase I Study of Fenretinide Lym-X-SorbTM (LX) Oral Powder in Patients with Recurrent or Resistant Neuroblastoma (New Agent)



Page modified on October 2, 2021
BCM Home     BCM Intranet     Privacy Notices     Contact BCM    BCM Site Map

© 2007 Baylor College of Medicine and Texas Children's Hospital

Texas Children's Cancer Center
and Hematology Service

Clinical Care Center, 14th floor
MAIL: 6621 Fannin St., CC 1410.00
Houston, Texas 77030-2399

Phone: 832-822-4200  |  Toll-free: 800-226-2379
Contact Us